Cargando…

Predictive value of using plasma long non-coding RNAs ANRIL and HOXA11-AS for in-stent restenosis

In-stent restenosis (ISR) can pose serious challenges for cardiologists following coronary stent implantation. Early identification of patients at high risk of ISR is considered to be effective for its prevention. However, factors that can reliably predict the risk of ISR remain elusive at present....

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Zhijiang, Shen, Hongfeng, Cha, Wei, Xia, Haijiang, Liu, Longbin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8713178/
https://www.ncbi.nlm.nih.gov/pubmed/34970338
http://dx.doi.org/10.3892/etm.2021.11038
_version_ 1784623718263160832
author Jin, Zhijiang
Shen, Hongfeng
Cha, Wei
Xia, Haijiang
Liu, Longbin
author_facet Jin, Zhijiang
Shen, Hongfeng
Cha, Wei
Xia, Haijiang
Liu, Longbin
author_sort Jin, Zhijiang
collection PubMed
description In-stent restenosis (ISR) can pose serious challenges for cardiologists following coronary stent implantation. Early identification of patients at high risk of ISR is considered to be effective for its prevention. However, factors that can reliably predict the risk of ISR remain elusive at present. The present study aimed to investigate the possible association between plasma long non-coding RNA (lncRNA) levels and ISR. A total of 410 patients with single-vessel lesion who received drug-eluting stents (DES) were included in the present study. After 12-36 months of follow-up, coronary angiography was performed and ISR was defined as >50% diameter stenosis at follow-up. RT-qPCR was used to measure lncRNA expression. Expression of the lncRNA RNA antisense non-coding RNA at the INK4 locus (ANRIL) was found to be upregulated whereas the lncRNA homeobox A11 antisense (HOXA11-AS) was downregulated in the plasma of patients with ISR compared with that from patients without ISR (P<0.001). Logistic regression analysis revealed that ANRIL [odds ratio (OR)=2.95; 95% confidence interval (CI)=1.68-8.08] was an independent risk factor for ISR, whilst HOXA11-AS (OR=0.58; 95% CI=0.48-0.71) was found to be an independent protective factor for ISR. Receiver operating characteristic (ROC) analysis demonstrated that high ANRIL expression [area under the ROC (auROC)=0.755; 95% CI=0.702-0.803] and low HOXA11-AS levels (auROC=0.712; 95% CI=0.657-0.763) predicted a high risk for ISR, and the combined score of ANRIL and HOXA11-AS (auROC=0.844; 95% CI=0.798-0.884) was more efficient at predicting ISR than either ANRIL or HOXA11-AS alone (P<0.001). In conclusion, increased ANRIL and decreased HOXA11-AS expressions were associated with ISR. However, combined ANRIL and HOXA11-AS plasma levels proved to be more effective at predicting ISR compared with either ANRIL or HOXA11-AS alone, suggesting that the multiplex detection of lncRNAs could be used to predict ISR in the future.
format Online
Article
Text
id pubmed-8713178
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-87131782021-12-29 Predictive value of using plasma long non-coding RNAs ANRIL and HOXA11-AS for in-stent restenosis Jin, Zhijiang Shen, Hongfeng Cha, Wei Xia, Haijiang Liu, Longbin Exp Ther Med Articles In-stent restenosis (ISR) can pose serious challenges for cardiologists following coronary stent implantation. Early identification of patients at high risk of ISR is considered to be effective for its prevention. However, factors that can reliably predict the risk of ISR remain elusive at present. The present study aimed to investigate the possible association between plasma long non-coding RNA (lncRNA) levels and ISR. A total of 410 patients with single-vessel lesion who received drug-eluting stents (DES) were included in the present study. After 12-36 months of follow-up, coronary angiography was performed and ISR was defined as >50% diameter stenosis at follow-up. RT-qPCR was used to measure lncRNA expression. Expression of the lncRNA RNA antisense non-coding RNA at the INK4 locus (ANRIL) was found to be upregulated whereas the lncRNA homeobox A11 antisense (HOXA11-AS) was downregulated in the plasma of patients with ISR compared with that from patients without ISR (P<0.001). Logistic regression analysis revealed that ANRIL [odds ratio (OR)=2.95; 95% confidence interval (CI)=1.68-8.08] was an independent risk factor for ISR, whilst HOXA11-AS (OR=0.58; 95% CI=0.48-0.71) was found to be an independent protective factor for ISR. Receiver operating characteristic (ROC) analysis demonstrated that high ANRIL expression [area under the ROC (auROC)=0.755; 95% CI=0.702-0.803] and low HOXA11-AS levels (auROC=0.712; 95% CI=0.657-0.763) predicted a high risk for ISR, and the combined score of ANRIL and HOXA11-AS (auROC=0.844; 95% CI=0.798-0.884) was more efficient at predicting ISR than either ANRIL or HOXA11-AS alone (P<0.001). In conclusion, increased ANRIL and decreased HOXA11-AS expressions were associated with ISR. However, combined ANRIL and HOXA11-AS plasma levels proved to be more effective at predicting ISR compared with either ANRIL or HOXA11-AS alone, suggesting that the multiplex detection of lncRNAs could be used to predict ISR in the future. D.A. Spandidos 2022-02 2021-12-06 /pmc/articles/PMC8713178/ /pubmed/34970338 http://dx.doi.org/10.3892/etm.2021.11038 Text en Copyright: © Jin et al. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
Jin, Zhijiang
Shen, Hongfeng
Cha, Wei
Xia, Haijiang
Liu, Longbin
Predictive value of using plasma long non-coding RNAs ANRIL and HOXA11-AS for in-stent restenosis
title Predictive value of using plasma long non-coding RNAs ANRIL and HOXA11-AS for in-stent restenosis
title_full Predictive value of using plasma long non-coding RNAs ANRIL and HOXA11-AS for in-stent restenosis
title_fullStr Predictive value of using plasma long non-coding RNAs ANRIL and HOXA11-AS for in-stent restenosis
title_full_unstemmed Predictive value of using plasma long non-coding RNAs ANRIL and HOXA11-AS for in-stent restenosis
title_short Predictive value of using plasma long non-coding RNAs ANRIL and HOXA11-AS for in-stent restenosis
title_sort predictive value of using plasma long non-coding rnas anril and hoxa11-as for in-stent restenosis
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8713178/
https://www.ncbi.nlm.nih.gov/pubmed/34970338
http://dx.doi.org/10.3892/etm.2021.11038
work_keys_str_mv AT jinzhijiang predictivevalueofusingplasmalongnoncodingrnasanrilandhoxa11asforinstentrestenosis
AT shenhongfeng predictivevalueofusingplasmalongnoncodingrnasanrilandhoxa11asforinstentrestenosis
AT chawei predictivevalueofusingplasmalongnoncodingrnasanrilandhoxa11asforinstentrestenosis
AT xiahaijiang predictivevalueofusingplasmalongnoncodingrnasanrilandhoxa11asforinstentrestenosis
AT liulongbin predictivevalueofusingplasmalongnoncodingrnasanrilandhoxa11asforinstentrestenosis